OYM
- Product code
- OYM
- Device name
- Prostrate Cancer Genes Nucleic Acid Amplification Test System
- Device class
- Class 3
- Medical specialty
- Unknown
- Marketing pathway
- PMA
FDA classification definition
An in vitro nucleic acid amplification test that measures the concentration of prostate cancer genes.
Official FDA classification page: OYM
Classification and pathway per current FDA publications. Data from openFDA (CC0).